Regeneron's Strategic Move in 23andMe Bankruptcy Acquisition
Reported 2 months ago
Regeneron is making headlines with its recent acquisition of 23andMe out of bankruptcy, presenting a unique twist in the ongoing saga of the biotech company's financial challenges and future potential.